{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T14:52:18Z","timestamp":1695826338594},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1994,3,1]],"date-time":"1994-03-01T00:00:00Z","timestamp":762480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[1994,3]]},"DOI":"10.1007\/bf01541342","type":"journal-article","created":{"date-parts":[[2005,4,19]],"date-time":"2005-04-19T23:24:08Z","timestamp":1113953048000},"page":"98-106","source":"Crossref","is-referenced-by-count":7,"title":["Anti-tetanus toxoid antibody production after mismatched T cell-depleted bone marrow transplantation"],"prefix":"10.1007","volume":"14","author":[{"given":"M.","family":"Benkerrou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. W.","family":"Wara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Elder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Dror","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. W.","family":"Colombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Garovoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJM198408023110506","volume":"311","author":"FS Rosen","year":"1984","unstructured":"Rosen FS, Cooper MD, Wedgwood RJP: The primary immunodeficiencies. N Engl J Med 311:300?310, 1984","journal-title":"N Engl J Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood.V73.8.2051.2051","volume":"73","author":"R Champlin","year":"1989","unstructured":"Champlin R, Gale RP: Acute lymphoblastic leukemia: recent advances in biology and therapy. Blood 73:2051?2066, 1989","journal-title":"Blood"},{"key":"CR3","first-page":"285","volume":"19","author":"JM Vossen","year":"1987","unstructured":"Vossen JM: Bone marrow transplantation in the treatment of primary immunodeficiencies. Ann Clin Res 19:285?292, 1987","journal-title":"Ann Clin Res"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1182\/blood.V74.6.2212.2212","volume":"74","author":"L Wijnaendts","year":"1989","unstructured":"Wijnaendts L, Le Deist F, Griscelli C, Fischer A: Development of immunologic functions after bone marrow transplantation in 33 patients with severe combined immunodeficiency. Blood 74:2212?2219, 1989","journal-title":"Blood"},{"key":"CR5","first-page":"129","volume-title":"Primary Immunodeficiency Diseases, Birth Defects, Vol 19","author":"RJ O'Reilly","year":"1983","unstructured":"O'Reilly RJ, Kapoor N, Kirkpatrick D, Flomenberg N, Pollack MS, Dupont B, Good RA, Reisner Y: Transplantation of hematopoietic cells for lethal congenital immunodeficiencies.In Primary Immunodeficiency Diseases, Birth Defects, Vol 19, RJ Wedgwood, FS Rosen, NW Paul (eds). New York, Liss, 1983, pp 129?137"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/0140-6736(90)92348-L","volume":"336","author":"A Fischer","year":"1990","unstructured":"Fischer A, Landais P, Friedrich W, Morgan G, Gerritsen B, Fasth A, Porta F, Griscelli C, Goldman SF, Levinsky R, Vossen J: European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet 336:850?4, 1990","journal-title":"Lancet"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.4049\/jimmunol.136.7.2398","volume":"136","author":"RH Buckley","year":"1986","unstructured":"Buckley RH, Schiff SE, Sampson HA, Schiff RI, Markert ML, Knutsen AP, Hershfield MS, Huang AT, Mickey GH, Ward FE: Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 136:2398?2407, 1986","journal-title":"J Immunol"},{"key":"CR8","first-page":"273","volume":"1","author":"RJ O'Reilly","year":"1989","unstructured":"O'Reilly RJ, Keever CA, Small TN, Brochstein J: The use of HLA-non-identical T-cell-depleted marrow transplants for correction of severe combined immunodeficiency disease. Immunodefic Rev 1:273?309, 1989","journal-title":"Immunodefic Rev"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V70.3.664.664","volume":"70","author":"RC Moen","year":"1987","unstructured":"Moen RC, Horowitz SD, Sondel PM, Borcherding WR, TrIGg ME, Billing R, Hong R: Immunologic reconstitution after haploidentical bone marrow transplantation for immune deficiency disorders: treatment of bone marrow cells with monoclonal antibody CT-2 and complement. Blood 70:664?669, 1987","journal-title":"Blood"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0090-1229(88)90020-7","volume":"48","author":"CA Keever","year":"1988","unstructured":"Keever CA, Flomenberg N, Brochstein J, Sullivan M, Collins NH, Burns J, Dupont B, O'Reilly RJ: Tolerance of engrafted donor T cells following bone marrow transplantation for severe combined immunodeficiency. Clin Immunol Immunopathol 48:261?276, 1988","journal-title":"Clin Immunol Immunopathol"},{"key":"CR11","first-page":"55","volume":"19","author":"RJ O'Reilly","year":"1987","unstructured":"O'Reilly RJ, Keever C, Kernan NA, Brochstein J, Collins N, Flomenberg N, Laver J, Emanuel D, Dupont B, Cunningham I, Castro-Malaspina H, Gulati S: HLA nonidentical T cell depleted marrow transplants: A comparison of results in patients treated for leukemia and severe combined immunodeficiency disease. Transplant Proc 19:55?60, 1987","journal-title":"Transplant Proc"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood.V81.8.2021.2021","volume":"81","author":"Y Dror","year":"1993","unstructured":"Dror Y, Gallagher R, Wara D, Colombe B, Merino A, Benkerrou M, Cowan MJ. Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation. Blood 81:2021?2030, 1993","journal-title":"Blood"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V74.1.1.1","volume":"74","author":"T Kishimoto","year":"1989","unstructured":"Kishimoto T: The biology of interleukin-6. Blood 74:1?10, 1989","journal-title":"Blood"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0092-8674(89)90121-9","volume":"57","author":"WE Paul","year":"1989","unstructured":"Paul WE: Pleiotropy and redundancy: T cell-derived lymphokines in the immune response. Cell 57:521?524, 1989","journal-title":"Cell"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0167-5699(88)91259-5","volume":"9","author":"A O'Garra","year":"1988","unstructured":"O'Garra A, Umland S, De France T, Christiansen J: ?B-cell factors? are pleiotropic. Immunol Today 9:45?54, 1988","journal-title":"Immunol Today"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF00915333","volume":"5","author":"MJ Cowan","year":"1985","unstructured":"Cowan MJ, Wara DW, Weintrub PS, Pabst H, Ammann AJ: Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean aiglutininnegative, T-depleted marrow cells. J Clin Immunol 5:370?376, 1985","journal-title":"J Clin Immunol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1084\/jem.154.4.1043","volume":"154","author":"HC Lane","year":"1981","unstructured":"Lane HC, Volkman DJ, Whalen G, Fauci AS: In vitro antigen induced, antigen-specific antibody production in man. Specific and polyclonal components, kinetics and cellular requirements. J Exp Med 154:1043?1057, 1981","journal-title":"J Exp Med"},{"key":"CR18","first-page":"49.1","volume-title":"Handbook of Experimental Immunology, Vol 2","author":"RM Steinman","year":"1986","unstructured":"Steinman RM, Voorhis WC, Spalding DM: Dendritic cells.In Handbook of Experimental Immunology, Vol 2, DM Weir, C Blackwell, LA Herzenberg (eds). Oxford, Blackwell Scientific, Publishers, 1986, pp 49.1?49.18"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1073\/pnas.83.9.2934","volume":"83","author":"D Pinkel","year":"1986","unstructured":"Pinkel D, Straume J, Gray JW: Cytogenetic analysis using quantitative high sensitivity, fluorescence hybridization. Proc Natl Acad Sci 83:2934?2938, 1986","journal-title":"Proc Natl Acad Sci"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.4049\/jimmunol.125.5.2347","volume":"125","author":"S Kishimoto","year":"1980","unstructured":"Kishimoto S, Tomino S, Mitsuya H, Fujiwara H, Tsuda H: Age-related decline in the in vitro and in vivo syntheses of anti-tetanus toxoid antibody in humans. J Immunol 125:2347?2352, 1980","journal-title":"J Immunol"},{"key":"CR21","first-page":"27.1","volume-title":"Handbook of Experimental Immunology, Vol 1","author":"RM Nakamura","year":"1986","unstructured":"Nakamura RM, Voller A, Bidwell DE: Enzyme immunoassays: Heterogeneous and homogeneous systems.In Handbook of Experimental Immunology, Vol 1, DM Weir, C Blackwell, LA Herzenberg (eds). Oxford, Blackwell Scientific, 1986, pp 27.1?27.20"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4049\/jimmunol.129.1.107","volume":"129","author":"DJ Volkman","year":"1982","unstructured":"Volkman DJ, Allyn SP, Fauci AS: Antigen-induced in vitro antibody production in humans: tetanus toxoid-specific antibody synthesis. J Immunol 129:107?112, 1982","journal-title":"J Immunol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1172\/JCI109234","volume":"62","author":"RH Stevens","year":"1978","unstructured":"Stevens RH, Saxon A: Immunoregulation in humans. Control of antitetanus toxoid antibody production after booster immunization. J Clin Invest 62:1154?1160, 1978","journal-title":"J Clin Invest"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0008-8749(79)90369-1","volume":"45","author":"RH Stevens","year":"1979","unstructured":"Stevens RH, Saxon A: Differential synthesis of IGM and IGG anti-tetanus toxoid antibody in vitro following in vivo booster immunization of humans. Cell Immunol 45:142?150, 1979","journal-title":"Cell Immunol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0008-8749(83)90152-1","volume":"82","author":"N Orcutt-Thordarson","year":"1983","unstructured":"Orcutt-Thordarson N, Lum LG: The regulatory roles of T4 and T8 subsets in tetanus toxoid-induced in vitro immunoglobulin production. Cell Immunol 82:184?195, 1983","journal-title":"Cell Immunol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI111341","volume":"73","author":"H Kodo","year":"1984","unstructured":"Kodo H, Gale RP, Saxon A: Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans. J Clin Invest 73:1377?1384, 1984","journal-title":"J Clin Invest"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4049\/jimmunol.135.1.185","volume":"135","author":"LG Lum","year":"1985","unstructured":"Lum LG, Culbertson NJ: The induction and suppression of in vitro IgG antitetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations. J Immunol 135:185?191, 1985","journal-title":"J Immunol"},{"key":"CR28","first-page":"377","volume":"50","author":"MK Brenner","year":"1983","unstructured":"Brenner MK, Newton CA, North ME, Weyman C, Ferrant J: The interaction of specific T-cell help and non-specific B-cell growth factors in the production of anti-tetanus antibody by human B cells grown in serum-free microcultures. Immunol 50:377?385, 1983","journal-title":"Immunol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.4049\/jimmunol.122.6.2498","volume":"122","author":"RH Stevens","year":"1979","unstructured":"Stevens RH, Macy E, Morrow C, Saxon A: Characterization of a circulating subpopulation of spontaneous anti-tetanus toxoid antibody producing B cells following in vivo booster immunization. J Immunol 122:2498?2504, 1979","journal-title":"J Immunol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1172\/JCI111218","volume":"73","author":"A Saxon","year":"1984","unstructured":"Saxon A, Barnett E: Human auto-antiidiotypes regulating T cell-mediated reactivity to tetanus toxoid. J Clin Invest 73:342?348, 1984","journal-title":"J Clin Invest"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4049\/jimmunol.122.2.592","volume":"122","author":"RH Stevens","year":"1979","unstructured":"Stevens RH, Saxon A: Reduced in vitro production of anti-tetanus toxoid antibody after repeated in vivo immunization with tetanus toxoid. J Immunol 122:592?598, 1979","journal-title":"J Immunol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00007890-198605000-00007","volume":"41","author":"S Shiobara","year":"1986","unstructured":"Shiobara S, Lum LG, Witherspoon RP, Storb R: Antigenspecific antibody responses of lymphocytes to tetanus toxoid after human marrow transplantation. Transplantation 41:587?592, 1986","journal-title":"Transplantation"},{"key":"CR33","first-page":"342","volume":"69","author":"L Flores-Romo","year":"1990","unstructured":"Flores-Romo L, Millsum MJ, Gillis S, Stubbs P, Sykes C, Gordon J: Immunoglobulin isotype production by cycling human B lymphocytes in response to recombinant cytokines and anti-IgM. Immunology 69:342?347, 1990","journal-title":"Immunology"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.4049\/jimmunol.143.7.2230","volume":"143","author":"DY Kunimoto","year":"1990","unstructured":"Kunimoto DY, Nordan RP, Strober W: IL-6 is a potent cofactor of IL-1 in IGM synthesis and of IL-5 in IGA synthesis. J Immunol 143:2230?2235, 1990","journal-title":"J Immunol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/eji.1830190724","volume":"19","author":"M Lundgren","year":"1989","unstructured":"Lundgren M, Persson U, Larsson P, Magnusson C, Smith CIE, Hammarstrom L, Severinson E: Interleukin 4 induces synthesis of IgE and IgG4 in human B cells. Eur J Immunol 19:1311?1315, 1989","journal-title":"Eur J Immunol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.4049\/jimmunol.143.12.4019","volume":"143","author":"DM Hilbert","year":"1989","unstructured":"Hilbert DM, Cancro MP, Scherle PA, Nordan RP, Van Snick J, Gerhard W, Rudikoff S: T cell derived IL-6 is differentially required for antigen-specific antibody secretion by primary and secondary B cells. J Immunol 143:4019?4024, 1989","journal-title":"J Immunol"},{"key":"CR37","first-page":"314","volume":"67","author":"K Kawakami","year":"1989","unstructured":"Kawakami K, Kakimoto K, Shinbori T, Onoue K: Signal delivery by physical interaction and soluble factors from accessory cells in the induction of receptor-mediated T-cell proliferation. Synergistic effect of BSF-2\/IL-6 and IL-1. Immunology 67:314?320, 1989","journal-title":"Immunology"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.4049\/jimmunol.144.4.1317","volume":"144","author":"K Kato","year":"1990","unstructured":"Kato K, Yokoi T, Takano N, Kanegane H, Yachie A, Miyawaki T, Taniguchi N: Detection by in situ hybridization and phenotypic characterization of cells expressing IL-6 mRNA in human stimulated blood. J Immunol 144:1317?1322, 1990","journal-title":"J Immunol"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0008-8749(90)90149-L","volume":"127","author":"A Lagoo","year":"1990","unstructured":"Lagoo A, Tseng CK, Sell S: Molecular signals in B cell activation. II. IL-2 mediated signals are required in late G1 for transition to S phase after ionomycin and PMA treatment. Cell Immunol 127:497?505, 1990","journal-title":"Cell Immunol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4049\/jimmunol.144.2.562","volume":"144","author":"JB Splawski","year":"1990","unstructured":"Splawski JB, McAnally LM, Lipsky PE: IL-2 dependance of the promotion of human B cell differentiation by IL-6 (BSF-2). J Immunol 144:562?569, 1990","journal-title":"J Immunol"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/334253a0","volume":"334","author":"O Lassila","year":"1988","unstructured":"Lassila O, Vainio O, Matzinger P: Can B cells turn on virgin T cells? Nature 334:253?255, 1988","journal-title":"Nature"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/334199a0","volume":"334","author":"AL DeFranco","year":"1988","unstructured":"DeFranco AL: Cell-cell interactions in the antibody response. Nature 334:199?200, 1988","journal-title":"Nature"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.4049\/jimmunol.145.9.2873","volume":"145","author":"ML Gougeon","year":"1990","unstructured":"Gougeon ML, Drean G, Le Deist F, Dousseau M, Fevrier M, Diu A, These J, Griscelli C, Fisher A: Human severe combined immunodeficiency disease: Phenotypic and functional characteristics of peripheral B lymphocytes. J Immunol 145:2873?2879, 1990","journal-title":"J Immunol"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4049\/jimmunol.143.1.84","volume":"143","author":"RS Geha","year":"1989","unstructured":"Geha RS, Rosen FS: The evolution of MHC restrictions in antigen recognition by T cells in a haploidentical bone marrow transplant recipient. J Immunol 143:84?88, 1989","journal-title":"J Immunol"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.4049\/jimmunol.143.5.1575","volume":"143","author":"JL Roberts","year":"1989","unstructured":"Roberts JL, Volkman DJ, Buckley RH: Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells. J Immunol 143:1575?1579, 1989","journal-title":"J Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01541342.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01541342\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01541342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:42:10Z","timestamp":1683074530000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01541342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,3]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,3]]}},"alternative-id":["BF01541342"],"URL":"https:\/\/doi.org\/10.1007\/bf01541342","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,3]]}}}